Bmc Cardiovasc Disor
-
Bmc Cardiovasc Disor · Aug 2015
Review Meta AnalysisColchicine in cardiac disease: a systematic review and meta-analysis of randomized controlled trials.
Colchicine has unique anti-inflammatory properties that may be beneficial in various cardiovascular conditions. This systematic review and meta-analysis of randomized controlled trials (RCTs) examines this issue. ⋯ Current RCT data suggests that colchicine may reduce the composite rate of cardiovascular adverse outcomes in a range of patients with established cardiovascular disease. Furthermore, colchicine reduces rates of recurrent pericarditis, post-pericardiotomy syndrome, and peri-procedural atrial fibrillation following cardiac surgery. Further RCTs evaluating the potential of colchicine for secondary prevention of cardiovascular events would be of interest.
-
Bmc Cardiovasc Disor · Aug 2015
The 100 most-cited articles on cardiovascular diseases from Mainland China.
China, as a rapidly developing country with the largest population of cardiologist in the world, has an increasing importance in the field of cardiology. However, the quantity and quality of research production in the field of cardiology is unclear. ⋯ This study provides a historical perspective on the scientific progress, and the trends in cardiovascular medicine in Mainland China.